[HLBANK] QoQ Cumulative Quarter Result on 30-Sep-2017 [#1]

Announcement Date
30-Nov-2017
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2018
Quarter
30-Sep-2017 [#1]
Profit Trend
QoQ- -70.21%
YoY- 17.75%
View:
Show?
Cumulative Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 4,839,565 3,663,251 2,407,185 1,178,630 4,550,649 3,398,731 2,274,982 65.63%
PBT 3,246,255 2,468,617 1,613,491 780,392 2,748,252 2,068,293 1,371,249 77.90%
Tax -608,177 -456,547 -291,452 -141,424 -603,236 -406,194 -278,687 68.48%
NP 2,638,078 2,012,070 1,322,039 638,968 2,145,016 1,662,099 1,092,562 80.27%
-
NP to SH 2,638,078 2,012,070 1,322,039 638,968 2,145,016 1,662,099 1,092,562 80.27%
-
Tax Rate 18.73% 18.49% 18.06% 18.12% 21.95% 19.64% 20.32% -
Total Cost 2,201,487 1,651,181 1,085,146 539,662 2,405,633 1,736,632 1,182,420 51.51%
-
Net Worth 23,893,507 23,340,592 23,197,104 23,319,839 22,684,628 22,091,076 21,824,994 6.24%
Dividend
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Div 981,924 327,300 327,296 - 920,476 306,820 306,818 117.63%
Div Payout % 37.22% 16.27% 24.76% - 42.91% 18.46% 28.08% -
Equity
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Net Worth 23,893,507 23,340,592 23,197,104 23,319,839 22,684,628 22,091,076 21,824,994 6.24%
NOSH 2,167,718 2,167,718 2,167,718 2,167,718 2,167,718 2,167,718 2,167,718 0.00%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin 54.51% 54.93% 54.92% 54.21% 47.14% 48.90% 48.03% -
ROE 11.04% 8.62% 5.70% 2.74% 9.46% 7.52% 5.01% -
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
RPS 236.58 179.08 117.68 57.62 222.47 166.16 111.22 65.62%
EPS 128.96 98.36 64.63 31.24 104.86 81.26 53.41 80.26%
DPS 48.00 16.00 16.00 0.00 45.00 15.00 15.00 117.61%
NAPS 11.68 11.41 11.34 11.40 11.09 10.80 10.67 6.23%
Adjusted Per Share Value based on latest NOSH - 2,167,718
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
RPS 236.08 178.70 117.43 57.50 221.99 165.80 110.98 65.63%
EPS 128.69 98.15 64.49 31.17 104.64 81.08 53.30 80.26%
DPS 47.90 15.97 15.97 0.00 44.90 14.97 14.97 117.60%
NAPS 11.6557 11.386 11.316 11.3758 11.066 10.7764 10.6466 6.24%
Price Multiplier on Financial Quarter End Date
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Date 29/06/18 30/03/18 29/12/17 29/09/17 30/06/17 31/03/17 30/12/16 -
Price 18.20 18.80 17.00 15.86 15.66 13.76 13.50 -
P/RPS 7.69 10.50 14.45 27.53 7.04 8.28 12.14 -26.30%
P/EPS 14.11 19.11 26.30 50.77 14.93 16.93 25.27 -32.26%
EY 7.09 5.23 3.80 1.97 6.70 5.91 3.96 47.60%
DY 2.64 0.85 0.94 0.00 2.87 1.09 1.11 78.46%
P/NAPS 1.56 1.65 1.50 1.39 1.41 1.27 1.27 14.73%
Price Multiplier on Announcement Date
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Date 28/08/18 30/05/18 26/02/18 30/11/17 24/08/17 29/05/17 21/02/17 -
Price 20.00 18.60 18.52 15.14 15.50 13.96 13.50 -
P/RPS 8.45 10.39 15.74 26.28 6.97 8.40 12.14 -21.51%
P/EPS 15.51 18.91 28.66 48.47 14.78 17.18 25.27 -27.84%
EY 6.45 5.29 3.49 2.06 6.77 5.82 3.96 38.55%
DY 2.40 0.86 0.86 0.00 2.90 1.07 1.11 67.44%
P/NAPS 1.71 1.63 1.63 1.33 1.40 1.29 1.27 22.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment